Specialty Networks is a leader in community urology care, providing innovative solutions using real-world data from approximately 4,000 urologists. Our focus includes uro-oncology insights, patient engagement, and clinical research. As the largest uro-oncology network, we integrate EMR, Practice Management, IOD, radiology systems and data curated with NLP transformed into meaningful insights. Through SN Research, we drive clinical trials and purpose-built registries, supporting various research solutions. Our vertically integrated network analyzes real-time urology data from 17 million patient lives, linked to external sources through the Datavant ecosystem for enhanced insights.
Using PPS Analytics, we provide precision data for clinical research feasibility assessments in community urology practices. It can also support the identification of appropriate and actionable candidates for planned and active clinical research trials, so recruitment goals are met on schedule.
The Specialty Networks vertically integrated urology network enables both physician practices and life sciences to analyze real world urology data in near real time. With robust connectivity, our data exceeds over 17 million unique patient lives as we collect data on a daily, weekly, and monthly basis from our large base of contributing urology practices.
Built on the solid foundation of PPS Analytics EMR data sets, SoNaR is the largest & deepest patient datast in uro-oncology. Our disease-specific, HIPAA-compliant, purpose-built registries to be used for Standards of Care, Life Sciences, and Research.
Real-world Comparison of Prostate-Specific Antigen Response in Patients with Metastatic Castration-Sensitive Prostate Cancer Treated with Apalutamide or Enzalutamide (PROMPT-1)
Presented at ASCO GU Cancers Symposium; 2024, January 25-27; San Franciso, CA
>> View Poster
Prostate-Specific Antigen Response Among Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide or Abiraterone Acetate in Real-World Urology Practices (PROMPT-2)
Presented at ASCO GU Cancers Symposium; 2024, January 25-27; San Franciso, CA
>> View Poster
© Copyright 2024 Specialty Networks